* Japanese*
Nagoya University , Faculty of Agriculture
2001.03 , Graduated
Kyoto University , Graduate School of Biostudies , Division of Integrated Life Science
Doctor Course , 2006.09 , Completed
Duty , Asahikawa Medical University School of Medicine Medical Course Basic Medicine Department of Advanced Medical Science , Associate Professor , 2020.09 -
Duty , Asahikawa Medical University Center for Advanced Research and Education , Associate Professor , 2017.04 - 2020.09
Japanese Association for Laboratory Animal Science
Japanese Cancer Association
Japanese Society for Vaccine-related Complications
Developmental biology
Genetics/Chromosome dynamics
Laboratory animal science
Cancer Science Institute of Singapore, National University of Singapore (SINGAPORE) , Research Fellow A , 2009.05 - 2010.12
English: Ueda J, Funakoshi H, Epigenome Editing for Treatment of Genetic and Infectious Diseases , Journal of Infectious Diseases & Therapy , 2023
English: Ueda J, Yamazaki T, Funakoshi H, Toward the Development of Epigenome Editing-Based Therapeutics: Potentials and Challenges , International Journal of Molecular Sciences , vol.24 (5) (p.4778 - ) , 2023
English: Itoi F, Miyamoto T, Himaki T, Honnma H, Sano M, Ueda J., Importance of real-time measurement of sperm head morphology in intracytoplasmic sperm injection. , Zygote , vol.30 (1) (p.9 - 16) , 2022
English: Kawabata H, Ono Y, Tamamura N, Oyama K, Ueda J, Sato H, Takahashi K, Taniue K, Okada T, Fujibayashi S, Hayashi A, Goto T, Enomoto K, Konishi H, Fujiya M, Miyakawa K, Tanino M, Nishikawa Y, Koga D, Watanabe T, Maeda C, Karasaki H, Liss AS, Mizukami Y, Okumura T., Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway. , J Gastroenterol. , 2022
English: Nagata M, Kosaka A, Yajima Y, Yasuda S, Ohara M, Ohara K, Harabuchi S, Hayashi R, Funakoshi H, Ueda J, Kumai T, Nagato T, Oikawa K, Harabuchi Y, Esteban C, Ohkuri T, Kobayashi H., A critical role of STING-triggered tumor-migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatment. , Cancer Immunol Immunother. , 2021
Partner division:Government Agency , 2020.07 - 2021.03
2020year , Representative , 1,800,000yen
Partner division:Private Enterprise , 2015.04 - 2016.03
2015year , Representative , 300,000yen
Updated on 2024/01/11
Copyright (C) 2012~ Asahikawa Medical University, All Rights Reserved.